7.27
非コンパートメント分析: 平均滞留時間
統計モーメント理論によると、平均滞留時間 (MRT) は薬物動態学の重要な指標です。MRT は、確率密度関数分布の期待平均として定義できます。体内での薬物分布に関する貴重な洞察を提供します。
静脈内ボーラス注射による薬物の投与後、薬物分子は体全体に分布し、さまざまな期間そこに留まります。MRT は、…
統計的モーメント理論によれば、平均滞留時間は確率密度関数分布の期待平均です。また、体内の薬物素因の観点から見ることもできます。
静脈内ボーラス投与後、薬物分子は分布し、さまざまな期間体内に存在します。
平均滞留時間は、薬物分子が体内に留まる平均時間を表します。
これは、モーメント対時間曲線 AUMC の下の面積と、濃度対時間曲線 AUC の下の 0 から無限大までの面積から計算できます。
AUMC は、対数線形の端子位相を仮定して、特定の点から無限遠に外挿できます。
ただし、AUMC は単回投与後にのみ計算でき、定常状態の条件下では計算できません。
その結果、ノンコンパートメントアプローチを使用して、単回薬物投与後の平均滞留時間を容易に計算できます
View the full transcript and gain access to JoVE Core videos
Q1: What is mean residence time in pharmacokinetics?
Mean residence time (MRT) is the expected mean of a probability density function distribution that describes the average time drug molecules stay in the body after administration. According to statistical moment theory, MRT provides valuable insights into drug disposition by quantifying how long a drug remains present in the system following an intravenous bolus injection.
Q2: How is mean residence time calculated from pharmacokinetic data?
Mean residence time is calculated using the ratio of the area under the moment-versus-time curve (AUMC) to the area under the concentration-versus-time curve (AUC), both integrated from zero to infinity. Since infinite measurement is impossible, a log-linear terminal phase assumption extrapolates AUMC to infinity from a given point, enabling accurate MRT computation.
Q3: Why can mean residence time only be calculated after single-dose administration?
Mean residence time calculation is limited to single-dose administration because the mathematical relationship between AUMC and AUC reflects the average residence time for one drug dose. At steady-state conditions with repeated dosing, this relationship breaks down, making MRT values unreliable for continuous or repeated dosing schedules.
Q4: What does the area under the moment-versus-time curve represent?
The area under the moment-versus-time curve (AUMC) provides information about the distribution and residence of drug molecules in the body over time. When combined with the area under the concentration-versus-time curve, AUMC enables calculation of mean residence time through the noncompartmental approach.
Q5: How does mean residence time relate to drug disposition in the body?
After intravenous bolus administration, drug molecules distribute throughout the body and reside there for varying periods. Mean residence time quantifies this disposition by representing the average duration these molecules remain in the system, offering clinicians insight into how quickly a drug is eliminated and how long therapeutic effects persist.
Q6: What is the noncompartmental approach in mean residence time analysis?
The noncompartmental approach is a model-independent methodology that calculates mean residence time using available data from single-dose administration without assuming specific compartment structures. This approach employs equations and algorithms to estimate MRT accurately by analyzing the relationship between AUMC and AUC values.
Q7: Why is the log-linear terminal phase assumption necessary for mean residence time calculation?
The log-linear terminal phase assumption allows extrapolation of the area under the moment-versus-time curve to infinity from a measured point, since it is impossible to obtain drug concentration measurements infinitely. This assumption enables practical calculation of mean residence time by providing a mathematical framework to estimate the tail of the AUMC curve.